ReviewVascular medicine (London, England)2012
Polyunsaturated fatty acids and peripheral artery disease.
Review in Vascular medicine (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation II
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
Who cites it
11 citing papers in PubMed, 27 citations in OpenAlex.
- Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).The Journal of surgical research · 2019Trial
- Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).Journal of the American Heart Association · 2015Trial
- n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.Vascular medicine (London, England) · 2013Trial
- Intake of marine n-3 polyunsaturated fatty acids and the risk of incident peripheral artery disease.European journal of clinical nutrition · 2021Article
- Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease.Journal of clinical medicine · 2020Article
- Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n-3 Polyunsaturated Fatty Acids.Lipids · 2019Article
- Advancing beyond the "heart-healthy diet" for peripheral arterial disease.Journal of vascular surgery · 2015Review
- Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.Journal of vascular surgery · 2014Observational
- Lipids in preventive dentistry.Clinical oral investigations · 2013Review
- Article
- Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion.The Journal of surgical research · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
There is substantial evidence that polyunsaturated fatty acids (PUFAs) such as n-3 and n-6 fatty acids (FAs) play an important role in prevention of atherosclerosis. In vitro and in vivo studies focusing on the interactions between monocytes and endothelial cells have explored the molecular effects of FAs on these interactions. Epidemiological surveys, followed by large, randomized, control trials have demonstrated a reduction in major cardiovascular events with supplementation of n-3 FAs in secondary prevention settings. The evidence of beneficial effects specific to patients with peripheral artery disease (PAD) remains elusive, and is the focus of this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.